PCV1- A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN AS PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH ESTABLISHED PERIPHERAL ARTERY DISEASE
Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-75.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71234-7/fulltext
Title :
PCV1- A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN AS PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH ESTABLISHED PERIPHERAL ARTERY DISEASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71234-7&doi=10.1046/j.1524-4733.2001.40202-75.x
First page :
Section Title :
Open access? :
No
Section Order :
126